tradingkey.logo
tradingkey.logo
検索

ReShape Lifesciences Inc

RSLS
ウォッチリストに追加
3.920USD
0.0000.00%
終値 07/02, 13:00ET15分遅れの株価
10.29M時価総額
損失額直近12ヶ月PER

詳細情報 ReShape Lifesciences Inc 企業名

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

ReShape Lifesciences Incの企業情報

企業コードRSLS
会社名ReShape Lifesciences Inc
上場日Oct 06, 2016
最高経営責任者「CEO」Mr. Paul F. Hickey
従業員数17
証券種類Ordinary Share
決算期末Oct 06
本社所在地1001 Calle Amanecer
都市SAN CLEMENTE
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号92673
電話番号19494296680
ウェブサイトhttps://www.reshapelifesciences.com/obalon/
企業コードRSLS
上場日Oct 06, 2016
最高経営責任者「CEO」Mr. Paul F. Hickey

ReShape Lifesciences Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

よくある質問

ReShape Lifesciences Incの上位5名の株主は誰ですか?

ReShape Lifesciences Incの上位5名の株主は以下のとおりです。Mr. Krishna Gupta

ReShape Lifesciences Inc(RSLS)の株式を保有している機関の数はいくつですか?

2026Q1時点で、ReShape Lifesciences Incの株式を保有している機関は34社あり、保有株式の総市場価値は約207.69Kで、全体の2.96%を占めています。2025Q4と比較して、機関の持ち株は148618.00増加しています。